Risk factors for metabolic syndrome independently predict arterial stiffness and endothelial dysfunction in patients with chronic kidney disease and minimal comorbidity

Diabetes Care

Volumn 35, Issue 8, 2012, Pages 1774-1780

  Lilitkarntakul, Pajaree ^a   Dhaun, Neeraj ^a,b   Melville, Vanessa ^a   Kerr, Debbie ^a   Webb, David J ^a   Goddard, Jane ^b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTERIAL STIFFNESS; ARTICLE; BODY MASS; CARDIOMETABOLIC RISK; CAROTID FEMORAL PULSE WAVE VELOCITY; CHRONIC KIDNEY DISEASE; COMORBIDITY; CONTROLLED STUDY; CREATININE CLEARANCE; DIASTOLIC BLOOD PRESSURE; DILATATION; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; FEMALE; FLOW MEDIATED DILATATION; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PREVALENCE; PULSE WAVE; RISK ASSESSMENT; SMOKING HABIT; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

ADULT; BLOOD GLUCOSE; BLOOD PRESSURE; COMORBIDITY; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RISK FACTORS; VASCULAR DISEASES; VASCULAR STIFFNESS;

EID: 84864387158     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc11-2345     Document Type: Article

References (39)

1. Sarnak MJ, Levey AS, Schoolwerth AC, et al.; American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003;108:2154-2169 (Pubitemid 37337595)
2. Zoccali C. Traditional and emerging cardiovascular and renal risk factors: an epidemiologic perspective. Kidney Int 2006;70:26-33 (Pubitemid 44000117)
3. Schiffrin EL, Lipman ML, Mann JF. Chronic kidney disease: effects on the cardiovascular system. Circulation 2007;116:85-97 (Pubitemid 47016250)
4. Lilitkarntakul P, Dhaun N, Melville V, et al. Blood pressure and not uraemia is the major determinant of arterial stiffness and endothelial dysfunction in patients with chronic kidney disease and minimal co-morbidity. Atherosclerosis 2011;216:217-225
5. Guérin AP, Pannier B, Métivier F, Marchais SJ, London GM. Assessment and significance of arterial stiffness in patients with chronic kidney disease. Curr Opin Nephrol Hypertens 2008;17:635-641
6. Blacher J, Guerin AP, Pannier B, Marchais SJ, SafarME, LondonGM. Impact of aortic stiffness on survival in end-stage renal disease. Circulation 1999;99:2434-2439 (Pubitemid 29218240)
7. Wilkinson IB, Franklin SS, Cockcroft JR. Nitric oxide and the regulation of large artery stiffness: from physiology to pharmacology. Hypertension 2004;44:112-116 (Pubitemid 39014221)
8. van Guldener C, Lambert J, Janssen MJ, Donker AJ, Stehouwer CD. Endothelium-dependent vasodilatation and distensibility of large arteries in chronic haemodialysis patients. Nephrol Dial Transplant 1997;12(Suppl 2):14-18 (Pubitemid 27331298)
9. Perticone F, Ceravolo R, Pujia A, et al. Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation 2001;104:191-196 (Pubitemid 32655837)
10. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C; American Heart Association; National Heart, Lung, and Blood Institute. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004;109:433-438 (Pubitemid 38133916)
11. Ahluwalia N, Drouet L, Ruidavets JB, et al. Metabolic syndrome is associated with markers of subclinical atherosclerosis in a French population-based sample. Atherosclerosis 2006;186:345-353
12. Sattar N, Gaw A, Scherbakova O, et al. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 2003;108:414-419 (Pubitemid 36935533)
13. van Popele NM,Westendorp IC, Bots ML, et al. Variables of the insulin resistance syndrome are associated with reduced arterial distensibility in healthy non-diabetic middle-aged women. Diabetologia 2000;43:665-672 (Pubitemid 30322085)
14. Ferreira I, Boreham CA, Twisk JW, et al. Clustering of metabolic syndrome risk factors and arterial stiffness in young adults: theNorthern Ireland YoungHearts Project. J Hypertens 2007;25:1009-1020 (Pubitemid 46573120)
15. Schillaci G, Pirro M, Vaudo G, et al. Metabolic syndrome is associated with aortic stiffness in untreated essential hypertension. Hypertension 2005;45:1078-1082 (Pubitemid 40770308)
16. Martens FM, van der Graaf Y, Dijk JM, Olijhoek JK, Visseren FL. Carotid arterial stiffness is marginally higher in the metabolic syndrome and markedly higher in type 2 diabetes mellitus in patients with manifestations of arterial disease. Atherosclerosis 2008;197:646-653 (Pubitemid 351417860)
17. Johnson DW, Armstrong K, Campbell SB, et al.Metabolic syndrome in severe chronic kidney disease: prevalence, predictors, prognostic significance and effects of risk factor modification. Nephrology (Carlton) 2007;12:391-398 (Pubitemid 47075413)
18. Chen J, Muntner P, Hamm LL, et al. The metabolic syndrome and chronic kidney disease inU.S. adults. Ann Intern Med 2004;140:167-174
19. Zhe XW, Zeng J, Tian XK, et al. Pulse wave velocity is associated with metabolic syndrome components in CAPD patients. Am J Nephrol 2008;28:641-646 (Pubitemid 351832451)
20. Anonymous; National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39(Suppl. 1):S1-S266
21. Anonymous; National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143-3421
22. O'Brien E, Mee F, Atkins N, Thomas M. Evaluation of three devices for self-measurement of blood pressure according to the revised British Hypertension Society Protocol: the Omron HEM-705CP, Philips HP5332, and Nissei DS-175. Blood Press Monit 1996;1:55-61 (Pubitemid 126441351)
23. Wilkinson IB, Fuchs SA, Jansen IM, et al. Reproducibility of pulse wave velocity and augmentation index measured by pulse wave analysis. J Hypertens 1998;16:2079-2084 (Pubitemid 29002391)
24. Corretti MC, Anderson TJ, Benjamin EJ, et al.; International Brachial Artery Reactivity Task Force. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002;39:257-265 (Pubitemid 34084631)
25. Oliver JJ, Bowler A, Beudeker Q, Cate T, Webb DJ. Dose-response relationship of sublingual nitroglycerin with brachial artery dilatation and change in central and peripheral augmentation index. Clin Pharmacol Ther 2005;77:337-338 (Pubitemid 40470390)
26. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41
27. Mafham MM, Niculescu-Duvaz I, Barron J, et al. A practical method of measuring glomerular filtration rate by iohexol clearance using dried capillary blood spots. Nephron Clin Pract 2007;106:c104-c112 (Pubitemid 47016328)
28. Young DO, Lund RJ, Haynatzki G, Dunlay RW. Prevalence of the metabolic syndrome in an incident dialysis population. Hemodial Int 2007;11:86-95 (Pubitemid 46128685)
29. Kovaite M, Petrulioniene Z, Ryliskyte L, et al. Systemic assessment of arterial wall structure and function in metabolic syndrome. Proc West Pharmacol Soc 2007;50:123-130
30. Czernichow S, Bertrais S, Blacher J, et al.; SU.VI.MAX. Vascular Study. Metabolic syndrome in relation to structure and function of large arteries: a predominant effect of blood pressure. A report from the SU.VI.MAX. Vascular Study. Am J Hypertens 2005;18:1154-1160 (Pubitemid 41337966)
31. Orr JS, Gentile CL, Davy BM, Davy KP. Large artery stiffening with weight gain in humans: role of visceral fat accumulation. Hypertension 2008;51:1519-1524
32. Elsayed EF, SarnakMJ, TighiouartH, et al. Waist-to-hip ratio, body mass index, and subsequent kidney disease and death. Am J Kidney Dis 2008;52:29-38 (Pubitemid 351853273)
33. Wendelhag I, Fagerberg B, Hulthe J, Bokemark L, Wikstrand J. Endothelium-dependent flow-mediated vasodilatation, insulin resistance and the metabolic syndrome in 60-year-old men. J Intern Med 2002;252:305-313 (Pubitemid 35253698)
34. Mattsson N, Rönnemaa T, Juonala M, et al. Arterial structure and function in young adults with the metabolic syndrome: the Cardiovascular Risk in Young Finns study. Eur Heart J 2008;29:784-791 (Pubitemid 351431012)
35. Scuteri A, Tesauro M, Rizza S, et al. Endothelial function and arterial stiffness in normotensive normoglycemic first-degree relatives of diabetic patients are independent of the metabolic syndrome. Nutr Metab Cardiovasc Dis 2008;18:349-356 (Pubitemid 351749803)
36. Ghiadoni L, Penno G, Giannarelli C, et al. Metabolic syndrome and vascular alterations in normotensive subjects at risk of diabetes mellitus. Hypertension 2008;51:440-445 (Pubitemid 351156430)
37. Golledge J, Leicht AS, Crowther RG, et al. Determinants of endothelial function in a cohort of patients with peripheral artery disease. Cardiology 2008;111:51-56
38. Lind L. Endothelium-dependent vasodilation, insulin resistance and the metabolic syndrome in an elderly cohort: the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study. Atherosclerosis 2008;196:795-802
39. Annuk M, Lind L, Linde T, Fellström B. Impaired endothelium- dependent vasodilatation in renal failure in humans. Nephrol Dial Transplant 2001;16:302-306 (Pubitemid 32123918)